Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Embecta Corporation (EMBC)
NASDAQ:EMBC
Embecta Corporation (EMBC) Stock Price & Analysis
41 Followers
EMBC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.93 - $30.98
Previous Close$10.88
Volume284.24K
Average Volume (3M)434.87K
Market Cap
$626.46M
Enterprise Value$1.96B
Total Cash (Recent Filing)$298.70M
Total Debt (Recent Filing)$1.64B
Price to Earnings (P/E)11.3
Beta0.58
Next Earnings
May 09, 2024EPS Estimate
$0.4Last Dividend Ex-Date
Feb 27, 2024Dividend Yield5.51%
Share Statistics
EPS (TTM)0.96
Shares Outstanding57,578,921
10 Day Avg. Volume426,757
30 Day Avg. Volume434,870
Standard Deviation0.13
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.75
Price to Sales (P/S)0.56
Price to Cash Flow (P/CF)-11.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.75
Enterprise Value/Gross Profit2.62
Enterprise Value/Ebitda72.78
Forecast
1Y Price Target
$17.00Price Target Upside56.11% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Embecta Corporation News
PremiumCompany Announcements
Embecta Shareholders Approve Directors and Compensation Plans
PremiumPress Releases
embecta Announces Quarterly Cash Dividend
Bulls Say, Bears Say
Bulls Say
Financial OutlookEmbecta kicked off the fiscal year surpassing consensus expectations on all key metrics and raised its adjusted EPS guidance.
Regulatory ApprovalEmbecta received IRS approval for a private letter ruling, allowing for a smoother transition.
Strategic PlanningExtension of the Transition Services Agreement provides stability and reduces risk of operational disruptions.
Bears Say
Company ValuationEMBC's cash flow value looks fully reflected in the current valuation, indicating limited upside potential for investors.
Sales Growth ConcernAnalysts highlight a lack of sales growth and uncertainty on long-term margin profile as EMBC aims to enter the T2D patch pump market.
Stock PerformanceEMBC shares experienced a significant drop in a recent trading session, highlighting potential volatility and investor concern.
---
Ownership Overview
1.65% Insiders
42.77% Mutual Funds
29.64% Other Institutional Investors
25.94% Public Companies and
Individual Investors
EMBC FAQ
What was Embecta Corporation’s price range in the past 12 months?
Embecta Corporation lowest stock price was $9.93 and its highest was $30.98 in the past 12 months.
What is Embecta Corporation’s market cap?
Currently, no data Available
When is Embecta Corporation’s upcoming earnings report date?
Embecta Corporation’s upcoming earnings report date is May 09, 2024 which is in 13 days.
How were Embecta Corporation’s earnings last quarter?
Embecta Corporation released its earnings results on Feb 09, 2024. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.455 by $0.155.
Is Embecta Corporation overvalued?
According to Wall Street analysts Embecta Corporation’s price is currently Undervalued.
Does Embecta Corporation pay dividends?
Embecta Corporation pays a Quarterly dividend of $0.15 which represents an annual dividend yield of 5.51%. See more information on Embecta Corporation dividends here
What is Embecta Corporation’s EPS estimate?
Embecta Corporation’s EPS estimate is $0.4.
How many shares outstanding does Embecta Corporation have?
Embecta Corporation has 57,578,922 shares outstanding.
What happened to Embecta Corporation’s price movement after its last earnings report?
Embecta Corporation reported an EPS of $0.61 in its last earnings report, beating expectations of $0.455. Following the earnings report the stock price went down -8.476%.
Which hedge fund is a major shareholder of Embecta Corporation?
Among the largest hedge funds holding Embecta Corporation’s share is Yacktman Asset Management LP. It holds Embecta Corporation’s shares valued at 51M.
---
Embecta Corporation Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$17.00 (56.11% Upside)
$17.00 (56.11% Upside)
Blogger Sentiment
Bullish
EMBC Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $32.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 9.2%
Last 30 Days ▼ 9.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.84%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
1.75%
Trailing 12-Months
Company Description
Embecta Corporation
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
---
EMBC Company Deck
---
EMBC Earnings Call
Q1 2024
0:00 / 0:00
---
EMBC Stock 12 Months Forecast
Average Price Target
$17.00
▲(56.11% Upside)
Technical Analysis
Best Analysts Covering EMBC
1 Year
1 Year Success Rate
5/5 ratings generated profit
1 Year Average Return
+40.56%
reiterated a sell rating 5 months ago
Copying Kallum Titchmarsh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +40.56% per trade.
---